Corteva, Inc. Reports Smaller Q3 Loss, Surpassing Expectations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 04 2025
0mins
Should l Buy CTVA?
Source: NASDAQ.COM
Quarterly Loss: Corteva, Inc. reported a third-quarter loss of $320 million (-$0.47 per share), an improvement from a loss of $524 million (-$0.76 per share) in the same period last year.
Adjusted Earnings: Excluding special items, the adjusted earnings for the quarter were -$156 million or -$0.23 per share, beating analysts' expectations of -$0.47 per share.
Revenue Growth: The company's revenue increased by 12.6% to $2.618 billion, up from $2.326 billion in the previous year.
Future Guidance: Corteva provided full-year EPS guidance of $3.25 - $3.35 and revenue guidance of $17.7 - $17.9 billion.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CTVA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CTVA
Wall Street analysts forecast CTVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CTVA is 79.17 USD with a low forecast of 68.00 USD and a high forecast of 86.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
10 Buy
2 Hold
0 Sell
Strong Buy
Current: 72.470
Low
68.00
Averages
79.17
High
86.00
Current: 72.470
Low
68.00
Averages
79.17
High
86.00
About CTVA
Corteva, Inc. is a global pure-play agriculture company. It is a global provider of seed and crop protection solutions focused on the agriculture industry and contributing to a healthier, secure and sustainable food supply. The Seed segment is engaged in developing and supplying commercial seed combining advanced germplasm and traits that produce optimum yield for farms around the world. It operates in various key seed markets, including North American corn and soybeans, European corn and sunflower, as well as Brazil, India, South Africa and Argentina corn. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that support overall crop health both above and below ground via nitrogen management and seed-applied technologies. Its crop protection solutions and digital solutions provide farmers with tools to improve productivity and help keep fields free of weeds, insects and diseases.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Cost and Yield Comparison: Vanguard Consumer Staples ETF (VDC) charges an annual fee of just 0.09%, significantly lower than Invesco Food & Beverage ETF (PBJ) at 0.61%, while VDC also offers a higher dividend yield of 2.1% compared to PBJ's 1.7%, making VDC more appealing for income-focused investors.
- Portfolio Composition Differences: VDC encompasses over 100 consumer stocks, with 98% in consumer defensive, whereas PBJ focuses on 31 food and beverage companies, including Sysco and Corteva, which may increase specific company risk due to its concentrated investments.
- Market Performance and Risk: Over the past year, VDC achieved a return of 4.6%, while PBJ only managed 1.2%, and VDC's maximum drawdown of 16.55% is lower than PBJ's 15.84%, indicating VDC's relative stability amid market volatility.
- Investment Strategy Choices: As a pure index fund, VDC provides comprehensive defensive exposure to consumer staples, while PBJ employs quantitative analysis for a concentrated portfolio, charging nearly seven times the fees of VDC, yet recent performance suggests this may not justify the cost, prompting investors to choose wisely.
See More
- Cakra Structure Overview: Corteva's stock entered Phase 4 in 2022 and formed a visible Cakra structure by the end of Phase 8 in November 2025, establishing a foundation for a breakout in Phase 9; however, the current trading position near the lower end of the Cakra indicates a lack of ideal breakout conditions.
- Increased Breakout Risk: Although Corteva initially bounced at the start of Phase 9, it has failed to decisively break above the upper boundary of the Cakra, facing repeated selling pressure, which suggests that if a breakout does not materialize, the risk of a significant downside increase is likely.
- Monthly Chart Warning: On the monthly charts, Corteva is currently in Phase 2 and has transitioned into the Buddhi segment, but the absence of prior consolidation during the Sankhya period further weakens the bullish case and adds to the structural caution already evident on the weekly charts.
- Investor Outlook: Investors should avoid chasing Corteva stock, and existing holders must closely monitor the Cakra structure, being prepared to act if a breakdown occurs, as a Cakra breakdown often indicates underlying fundamental risks that may not yet be fully reflected in the stock price.
See More
- Rating Downgrade: J.P. Morgan downgraded Corteva (CTVA) from Overweight to Neutral, citing that the stock is trading close to fair value despite improving fundamentals in the seed business, indicating limited upside potential.
- Price Target Increase: The bank raised its December 2026 price target from $75 to $77, reflecting an increase in its 2026 EBITDA forecast to $4.2 billion, driven by stronger-than-expected profitability in seeds.
- Cyclical Considerations: Analysts noted that U.S. corn acreage reached nearly 99 million acres in 2025, suggesting that Corteva is operating in a strong agricultural cycle, which could temper future earnings momentum.
- Separation Plan Impact: Corteva plans to split into two standalone companies in the second half of 2026, and the market may wait for clearer visibility on this separation before reassessing valuation multiples, even as the seed unit continues to show solid margins and market share gains.
See More
- Analyst Rating Updates: Top Wall Street analysts have adjusted their ratings on several companies, reflecting a shift in market sentiment regarding their prospects, which could influence investor decisions and market trends.
- Overview of Changes: While specific upgrades and downgrades are not detailed, the overall rating changes may lead to short-term volatility in related stocks, prompting investors to closely monitor these shifts.
- Expected Market Reaction: Analyst rating adjustments typically trigger immediate market responses, especially when investor interest in specific stocks increases, potentially impacting short-term price movements.
- Investor Focus: For those considering purchasing GOOGL stock, analysts' perspectives will serve as a crucial reference point, potentially affecting their investment decisions and market confidence.
See More
- Analyst Rating Updates: Top Wall Street analysts have adjusted their ratings on several companies, indicating a shift in market sentiment that could influence investor decisions and market trends.
- Upgrades and Downgrades: The rating changes include both upgrades and downgrades for certain stocks, prompting investors to pay attention to these shifts to assess potential investment opportunities and risks.
- Market Reaction Expectations: Analyst rating adjustments typically trigger immediate market reactions, and investors should closely monitor how these changes impact stock prices to timely adjust their investment strategies.
- Comprehensive Rating View: For a complete overview of all analyst rating changes, including upgrades, downgrades, and initiations, it is recommended to visit the analyst ratings page for detailed data and analysis.
See More
- Separation Progress: CEO Charles Magro highlighted that Corteva is on track for a separation in Q4 2025, with announcements for a new CEO and SpinCo brand identity expected in the first half, laying a strategic foundation for future growth.
- Impact of Bayer Agreement: The comprehensive resolution with Bayer is projected to generate about $1 billion in earnings upside over the next decade, allowing SpinCo to focus on value creation opportunities while reducing uncertainties from ongoing litigation.
- Financial Performance Highlights: Despite a 4% year-over-year decline in organic sales for Q4, the company achieved a 4% growth in annual organic sales, with operating EBITDA reaching $3.85 billion and EBITDA margins exceeding 22% for the first time, showcasing significant improvements in cost control and profitability.
- 2026 Outlook: Corteva reiterated its 2026 operating EBITDA guidance at a midpoint of $4.1 billion, expecting approximately 7% growth, while planning to repurchase about $500 million in shares in the first half, further enhancing shareholder returns.
See More











